Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
25.08
-0.61 (-2.37%)
Nov 17, 2026, 3:00 PM CST

SHA:688319 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,16810,2944,3036,4175,62114,513
Market Cap Growth
0.96%139.25%-32.95%14.17%-61.27%-
Enterprise Value
10,51510,4824,4226,2675,42014,115
Last Close Price
25.0825.3610.6015.7413.8135.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-462.46207.29365.54211.50134.42
Forward PE
-187.8598.6160.7738.4459.68
PS Ratio
12.7714.627.3112.9410.2729.79
PB Ratio
11.3611.394.616.906.3017.18
P/TBV Ratio
11.6011.614.747.136.5117.47
P/FCF Ratio
-1540.54----
P/OCF Ratio
565.0297.58-145.85-363.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.2114.897.5112.639.9028.97
EV/EBITDA Ratio
87.26158.3487.75204.71135.49120.71
EV/EBIT Ratio
133.03320.25204.541787.91368.70150.33
EV/FCF Ratio
-1568.66----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.570.480.390.260.150.05
Debt / EBITDA Ratio
4.226.156.696.933.350.33
Debt / FCF Ratio
-64.80----
Net Debt / Equity Ratio
0.390.200.13-0.13-0.25-0.49
Net Debt / EBITDA Ratio
2.992.782.38-4.07-5.63-3.56
Net Debt / FCF Ratio
-3.2627.51-0.550.991.0013.99
Asset Turnover
0.390.370.340.320.410.53
Inventory Turnover
1.190.850.380.490.560.47
Quick Ratio
1.191.231.371.801.632.34
Current Ratio
1.301.351.531.961.782.56
Return on Equity (ROE)
-3.44%2.38%1.69%1.26%3.06%17.68%
Return on Assets (ROA)
2.43%1.07%0.79%0.14%0.68%6.33%
Return on Invested Capital (ROIC)
-6.97%2.10%1.64%0.35%1.63%26.12%
Return on Capital Employed (ROCE)
6.10%2.50%1.80%0.30%1.50%10.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.32%0.22%0.48%0.27%0.47%0.74%
FCF Yield
-1.05%0.07%-5.04%-1.96%-4.01%-0.21%
Dividend Yield
---0.24%--
Payout Ratio
-66.11%142.97%34.11%16.00%0.95%
Buyback Yield / Dilution
-0.12%-0.01%0.01%-0.07%-5.22%-5.61%
Total Shareholder Return
-0.12%-0.01%0.01%0.17%-5.22%-5.61%